Literature DB >> 8405696

Postprandial free fatty acid kinetics are abnormal in upper body obesity.

L R Roust1, M D Jensen.   

Abstract

Excess free fatty acid release (rate of appearance) is seen in overnight postabsorptive, upper body obese women and, if present postprandially, could contribute to glucose intolerance. These studies examine the antilipolytic effect of a mixed meal in upper body obese, lower body obese, and nonobese women and the contribution of meal triglyceride fatty acids to circulating free fatty acids. Eight upper body obese, 8 lower body obese, and 8 nonobese age-matched, premenopausal women were studied. Systemic oleate Ra ([3H]oleate) was measured before and after an evening meal that contained triolein labeled with [14C]triolein as the only source of fat. Premeal oleate Ra was greater in both upper body obese and lower body obese women than nonobese women. The nadir of total oleate Ra occurred 90-240 min postprandially and was less (P < 0.01) in nonobese and lower body obese women (63 +/- 10 and 87 +/- 17 mumol/min) than in upper body obese women (140 +/- 21 mumol/min). Meal oleate Ra contributed substantially to total oleate Ra. The nadir for endogenous oleate Ra in nonobese and lower body obese women was less (P < 0.01) than that observed in upper body obese women. We conclude that the antilipolytic effect of a mixed meal is reduced in upper body obese women and that meal triglyceride fatty acids contribute significantly to postprandial free fatty acid flux.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405696     DOI: 10.2337/diab.42.11.1567

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  47 in total

Review 1.  Nonesterified fatty acids in blood pressure control and cardiovascular complications.

Authors:  B M Egan; E L Greene; T L Goodfriend
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 2.  Postprandial metabolism of meal triglyceride in humans.

Authors:  Jennifer E Lambert; Elizabeth J Parks
Journal:  Biochim Biophys Acta       Date:  2012-01-17

3.  Postprandial lipaemia induces an acute decrease of insulin sensitivity in healthy men independently of plasma NEFA levels.

Authors:  M T Pedrini; A Niederwanger; M Kranebitter; C Tautermann; C Ciardi; T Tatarczyk; J R Patsch
Journal:  Diabetologia       Date:  2006-04-26       Impact factor: 10.122

4.  Pioglitazone increases non-esterified fatty acid clearance in upper body obesity.

Authors:  S Shadid; M D Jensen
Journal:  Diabetologia       Date:  2005-12-02       Impact factor: 10.122

Review 5.  Yin and Yang of hypothalamic insulin and leptin signaling in regulating white adipose tissue metabolism.

Authors:  Thomas Scherer; Christoph Buettner
Journal:  Rev Endocr Metab Disord       Date:  2011-09       Impact factor: 6.514

6.  Lean NAFLD: An Underrecognized Outlier.

Authors:  Julia Wattacheril; Arun J Sanyal
Journal:  Curr Hepatol Rep       Date:  2016-04-14

7.  Gender differences in regional fatty acid metabolism before and after meal ingestion.

Authors:  M D Jensen
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

8.  Free fatty acid-induced hepatic insulin resistance is attenuated following lifestyle intervention in obese individuals with impaired glucose tolerance.

Authors:  Jacob M Haus; Thomas P J Solomon; Christine M Marchetti; John M Edmison; Frank González; John P Kirwan
Journal:  J Clin Endocrinol Metab       Date:  2009-11-11       Impact factor: 5.958

Review 9.  Role of body fat distribution and the metabolic complications of obesity.

Authors:  Michael D Jensen
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

10.  Increased postprandial nonesterified fatty acid appearance and oxidation in type 2 diabetes is not fully established in offspring of diabetic subjects.

Authors:  François Normand-Lauzière; Frédérique Frisch; Sébastien M Labbé; Patrick Bherer; René Gagnon; Stephen C Cunnane; André C Carpentier
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.